n/a
Article Publish Status: FREE
Abstract Title:

mcIRBP-19 of Bitter Melon Peptide Effectively Regulates Diabetes Mellitus (DM) Patients' Blood Sugar Levels.

Abstract Source:

Nutrients. 2020 Apr 28 ;12(5). Epub 2020 Apr 28. PMID: 32354072

Abstract Author(s):

Pang-Kuei Hsu, Frank F C Pan, Ching-Sen Hsieh

Article Affiliation:

Pang-Kuei Hsu

Abstract:

This study was conducted to test the effectiveness of a particular bitter melon peptide (BMP), with a specific sequence of 19 amino acids (mcIRBP-19), in regulating diabetic patients' blood glucose. In order to test the product with the specially processed BMP, a total of 142 diabetic patients were solicited as study subjects, of which 64 were assigned to an experiment group and 78 to a control group. Biochemical data were compared with a pairedtest to verify the significance of changes over different time periods. The clinical results showed that BMP started to improve the subjects' glycated hemoglobin (HbA1c) levels at the end of the second month (T2), with mean values being significantly lowered from 7.8± 1.4% (T0) to 7.5 ± 1.4% (T2) (= 0.004). The values reduced continuously, eventually reaching 7.4± 1.1% (= 0.000) at the end of the experiment (T3). HbA1c levels for the control group were 7.5± 1.2% in T0 and 7.5 ± 1.1% (T3), and not significantly different (= 0.852) over the same period. This study provides clinical evidence that helps to verify the effectiveness of the new BMP product in regulating diabetic patients' blood sugar levels.

Study Type : Human Study

Print Options


Key Research Topics

This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.